PubRank

James M Galloway

Author PubWeight™ 42.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007 4.20
2 Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 2008 3.16
3 Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006 2.90
4 Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study. Stroke 2005 1.96
5 Effect of statins alone versus statins plus ezetimibe on carotid atherosclerosis in type 2 diabetes: the SANDS (Stop Atherosclerosis in Native Diabetics Study) trial. J Am Coll Cardiol 2008 1.91
6 Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study. Circulation 2007 1.78
7 Incidence and risk factors for stroke in American Indians: the Strong Heart Study. Circulation 2008 1.67
8 American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation 2013 1.66
9 Repolarization abnormality for prediction of all-cause and cardiovascular mortality in American Indians: the Strong Heart Study. J Cardiovasc Electrophysiol 2005 1.47
10 Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study. Circulation 2006 1.46
11 Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care 2007 1.42
12 Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study. J Hypertens 2010 1.16
13 Scientific statement: Socioecological determinants of prediabetes and type 2 diabetes. Diabetes Care 2013 1.09
14 Electrocardiographic repolarization complexity and abnormality predict all-cause and cardiovascular mortality in diabetes: the strong heart study. Diabetes 2004 1.07
15 Principal component analysis of the T wave and prediction of cardiovascular mortality in American Indians: the Strong Heart Study. Circulation 2002 1.04
16 PREVENTION OF ATHEROSCLEROSIS WITH LDL-C LOWERING - LIPOPROTEIN CHANGES AND INTERACTIONS: THE SANDS STUDY. J Clin Lipidol 2009 1.02
17 Taking the initiative: implementing the American Heart Association Guide for Improving Cardiovascular Health at the Community Level: Healthy People 2010 Heart Disease and Stroke Partnership Community Guideline Implementation and Best Practices Workgroup. Circulation 2005 0.98
18 Cardiovascular health in indigenous communities: successful programs. Heart Lung Circ 2010 0.89
19 Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Advocacy Writing Group. Circulation 2005 0.89
20 Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the Strong Heart Study. J Am Coll Cardiol 2002 0.89
21 Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial. J Clin Hypertens (Greenwich) 2009 0.89
22 Mental health effects of the gulf oil spill. Disaster Med Public Health Prep 2010 0.86
23 Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study. Hypertension 2004 0.85
24 C-reactive protein and electrocardiographic ST-segment depression additively predict mortality: the Strong Heart Study. J Am Coll Cardiol 2005 0.85
25 The increasing incidence of coronary artery disease and cardiovascular risk factors among a Southwest Native American tribe: the White Mountain Apache Heart Study. Arch Intern Med 2002 0.85
26 Cardiac procedure use following acute myocardial infarction among American Indians. Am Heart J 2006 0.84
27 Hyperlipidemia in Native Americans: evaluation of lipid management through a cardiovascular risk reduction program. J Am Pharm Assoc (Wash) 2002 0.84
28 Aspirin in the secondary prevention of cardiovascular disease. N Engl J Med 2013 0.83
29 The ratio of mitral deceleration time to E-wave velocity and mitral deceleration slope outperform deceleration time alone in predicting cardiovascular outcomes: the Strong Heart Study. J Am Soc Echocardiogr 2007 0.82
30 Usefulness of quantitative assessment of electrocardiographic ST depression for predicting new-onset heart failure in American Indians (from the Strong Heart Study). Am J Cardiol 2007 0.81
31 Utility of the myocardial performance index in a population with high prevalences of obesity, diabetes, and hypertension: the strong heart study. Echocardiography 2007 0.81
32 Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) . J Clin Lipidol 2010 0.77
33 Acute myocardial infarction quality of care: the Strong Heart Study. Ethn Dis 2011 0.75
34 Prevalence and correlates of rheumatic heart disease in American Indians (the Strong Heart Study). Am J Cardiol 2003 0.75